HST Global Inc

HST Global operates with a capital structure that includes total assets of $6.19 million and total liabilities of $610,980, resulting in a debt-to-equity ratio of 0.05. The company's liquidity position is weak, with a current ratio of 0.08 and only $28,800 in cash and equivalents. The negative operating and free cash flows of -$126,780 and -$174,570, respectively, indicate a lack of liquidity to sustain operations without external financing. Profitability metrics show significant underperformance relative to industry norms. The company reported a net loss of $212,620 and an operating loss of $210,660, with return on equity and return on assets of -3.81% and -3.44%, respectively. These figures suggest that HST Global is not generating returns that meet the cost of capital or industry expectations. The company has not disclosed any revenue or segment-specific financial data, and its geographic exposure is not detailed in the available information. Given the absence of revenue and the focus on wellness centers and alternative treatments for late-stage cancer, the company's operations are likely concentrated in a few locations or product lines, though specifics are not provided. HST Global has not generated any revenue to date, and there are no disclosed growth metrics or revenue history to assess its trajectory. The company's outlook for the current and next fiscal years is not quantified, but the lack of revenue and ongoing losses suggest a challenging path to profitability. The absence of revenue and the need for continued capital raises questions about the company's ability to scale or achieve meaningful growth. The company faces significant financial risks, including a medium liquidity risk and a negative net cash position after subtracting total debt. The dilution risk is currently assessed as low, but the company's reliance on external financing to fund operations could increase the likelihood of future dilution. The lack of revenue and ongoing losses also suggest a high operational risk, as the company must secure additional capital to continue operations. Recent events and disclosures indicate that HST Global has not generated any revenue and is operating at a loss. The company's focus on developing and acquiring wellness centers and alternative treatments for late-stage cancer is outlined in its business description, but there are no recent filings or transcripts that provide additional insight into its strategic direction or progress.